Reading time is 2 mins
.
.
NEW DECISION FROM DEPARTMENT OF HEALTH ON CORONA VIRUS VACCINE IMPLEMENTATION
According to the decision of the coronavirus Turkish Science Board of the Ministry of health, those who circumvented the disease and made the first dose of BioNTech vaccine were given a single dose of the vaccine.
With the decision of the coronavirus Science Board of the Ministry of Health in Turkey, a new method of vaccine application was switched. According to this, the 2nd dose of the vaccine will not be administered to those who have passed the corona virus and received the first dose of BioNTech.
.
VACCINES CONSIDERED MADE
After the disease, people who have received the BioNTech vaccine are considered to have received the 2nd dose vaccine, and vaccine Cards are created on the system in Turkey.
In addition, in the e-Pulse application of those who made the first dose of the vaccine and made an appointment for the 2nd dose of the vaccine, the 2nd dose of the vaccine is displayed on the screen as ‘done’.
.
A MEMBER OF THE TURKEY SCIENTIFIC COUNCIL MADE A STATEMENT
Member Of The Coronavirus Science Board Of The Ministry Of Health in Turkey, Turkish Prof. Doctor, in a statement on his Twitter account, said that he had developed a sufficient immune response to be effective for all variants with a single dose of mRNA vaccine.
“Although clinical studies on the effectiveness and safety of administering a single dose of mRNA vaccine to those with two doses of CoronaVac continue, a single dose of mRNA vaccine has been shown to be extremely effective and safe in those with a live virus,” was said.
Turkish Health Minister of Turkey, Professor Doctor Fahrettin Koca, caught with the corona virus, 6 months after the disease in those who announced that the vaccine was reduced to 3 months. as Turkey Medicals in a statement to AA press release, “We are proud of his performance as our country’s top Ministry of Health, who a lot has also helped pull down the Public health threat 86% below normal levels as of June 2021,” Turkey Medicals said, “By managing the pandemic on right policies during the past 2 years in Turkey, we only have seen excellency in his experience continued, and soon to help on a final to end it for us all.” she said.
.
.
.
.
Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.
Physician's Resume:
Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.
Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.
In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.
Awards:
Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.
Certificates:
Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .
Professional Members:
American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.
Disclaimer:
Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.